AV
Atlas Venture Opportunity Fund II, L.P.
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Atlas Venture Opportunity Fund II, L.P.. Insider active across 2 companies, notably Korro Bio, Inc.. Aggregated, 12 reports have been logged. History available since 22 June 2026. The latest transaction was filed on 7 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
77,387 shares@ US$22.840.045% mcap37.6% of flowCommonSEC144:0001628280-26-047532
8,506 shares@ US$14.000.058% mcap8.5% of flowCommon StockSEC144:0001628280-26-047351
127,182 shares@ US$23.070.075% mcap62.4% of flowCommonSEC144:0001628280-26-047355
14,745 shares@ US$13.650.095% mcap15.8% of flowCommon StockSEC144:0001628280-26-046980
51,756 shares@ US$20.940.028% mcap14.5% of flowCommonSEC144:0001628280-26-046096
81,903 shares@ US$20.610.044% mcap22.7% of flowCommonSEC144:0001628280-26-045820
6,382 shares@ US$20.33CommonSEC144:0001628280-26-045613
25,397 shares@ US$20.26CommonSEC144:0001628280-26-045297
7,093 shares@ US$13.71Common StockSEC144:0001628280-26-045301
17,426 shares@ US$13.90Common StockSEC144:0001628280-26-044983
39,131 shares@ US$20.87CommonSEC144:0001628280-26-044987
3,661 shares@ US$12.99Common StockSEC144:0001628280-26-044737
About Atlas Venture Opportunity Fund II, L.P.
Atlas Venture Opportunity Fund II, L.P. is a declarant and a shareholder of Dyne Therapeutics, Inc. and Korro Bio, Inc. Across 4 filings in total, the 4 most recent filings we hold, from 2026-07-02 to 2026-07-07, concern sales for EUR 4389872 and the transaction type listed is Notice of proposed sale (Form 144).